CAS enhances chemotherapeutic drug-induced p53 accumulation and apoptosis: Use of CAS for high-sensitivity anticancer drug screening

Ching Fong Liao, Shue Fen Luo, Chin Shaw Stella Tsai, Tang Yi Tsao, Shun Liang Chen, Ming Chung Jiang

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Cells attacked by cytotoxic toxins may express apoptosis-related proteins such as p53 to kill themselves, so as not to affect surrounding healthy cells. These apoptosis-related proteins are also crucial for inducing apoptosis of tumor cells in cancer chemotherapy. CSE1L/CAS is a cellular apoptosis susceptibility protein that plays important roles in mediating cell apoptosis induced by various cytotoxic toxins and chemotherapeutic drugs. Our studies showed that CAS over-expression increased p53 accumulation and apoptosis induced by 5-fluorouracil, doxorubicin, cisplatin, and tamoxifen in HT-29 cancer cells. A method based on coexpression of CAS with green fluorescence protein (GFP) was developed for high-sensitivity anticancer drug screening. Cancer cells transfected with CAS- and GFP-expressing vectors or the control and GFP-expressing vectors were grown on 96-well microplates, treated with compounds to be screened, and detected with a microplate fluorescence reader. GFP fluorescence decreased following cancer cell death induced by the anticancer compounds. CAS transfection enhanced the cytotoxicities of anticancer compounds and therefore increased the decline in GFP fluorescence. Thus, anticancer compounds could be identified more sensitively. Our study indicates that CAS is an important p53 and apoptosis regulator and may be used for high-throughput anticancer drug screening as well as cytotoxic toxin assays.

Original languageEnglish
Pages (from-to)771-776
Number of pages6
JournalToxicology Mechanisms and Methods
Volume18
Issue number9
DOIs
Publication statusPublished - Nov 2008

Fingerprint

Preclinical Drug Evaluations
Screening
Fluorescence
Apoptosis
Pharmaceutical Preparations
Cells
Proteins
Neoplasms
Cellular Apoptosis Susceptibility Protein
HT29 Cells
Chemotherapy
Cell death
Tamoxifen
Cytotoxicity
Fluorouracil
Doxorubicin
Cisplatin
Transfection
Tumors
Assays

Keywords

  • Anticancer drugs
  • Apoptosis
  • CAS
  • Green fluorescence protein
  • High-throughput screening
  • p53

ASJC Scopus subject areas

  • Toxicology
  • Health, Toxicology and Mutagenesis

Cite this

CAS enhances chemotherapeutic drug-induced p53 accumulation and apoptosis : Use of CAS for high-sensitivity anticancer drug screening. / Liao, Ching Fong; Luo, Shue Fen; Tsai, Chin Shaw Stella; Tsao, Tang Yi; Chen, Shun Liang; Jiang, Ming Chung.

In: Toxicology Mechanisms and Methods, Vol. 18, No. 9, 11.2008, p. 771-776.

Research output: Contribution to journalArticle

Liao, Ching Fong ; Luo, Shue Fen ; Tsai, Chin Shaw Stella ; Tsao, Tang Yi ; Chen, Shun Liang ; Jiang, Ming Chung. / CAS enhances chemotherapeutic drug-induced p53 accumulation and apoptosis : Use of CAS for high-sensitivity anticancer drug screening. In: Toxicology Mechanisms and Methods. 2008 ; Vol. 18, No. 9. pp. 771-776.
@article{843f4ec86b354271a26b08a124e6d795,
title = "CAS enhances chemotherapeutic drug-induced p53 accumulation and apoptosis: Use of CAS for high-sensitivity anticancer drug screening",
abstract = "Cells attacked by cytotoxic toxins may express apoptosis-related proteins such as p53 to kill themselves, so as not to affect surrounding healthy cells. These apoptosis-related proteins are also crucial for inducing apoptosis of tumor cells in cancer chemotherapy. CSE1L/CAS is a cellular apoptosis susceptibility protein that plays important roles in mediating cell apoptosis induced by various cytotoxic toxins and chemotherapeutic drugs. Our studies showed that CAS over-expression increased p53 accumulation and apoptosis induced by 5-fluorouracil, doxorubicin, cisplatin, and tamoxifen in HT-29 cancer cells. A method based on coexpression of CAS with green fluorescence protein (GFP) was developed for high-sensitivity anticancer drug screening. Cancer cells transfected with CAS- and GFP-expressing vectors or the control and GFP-expressing vectors were grown on 96-well microplates, treated with compounds to be screened, and detected with a microplate fluorescence reader. GFP fluorescence decreased following cancer cell death induced by the anticancer compounds. CAS transfection enhanced the cytotoxicities of anticancer compounds and therefore increased the decline in GFP fluorescence. Thus, anticancer compounds could be identified more sensitively. Our study indicates that CAS is an important p53 and apoptosis regulator and may be used for high-throughput anticancer drug screening as well as cytotoxic toxin assays.",
keywords = "Anticancer drugs, Apoptosis, CAS, Green fluorescence protein, High-throughput screening, p53",
author = "Liao, {Ching Fong} and Luo, {Shue Fen} and Tsai, {Chin Shaw Stella} and Tsao, {Tang Yi} and Chen, {Shun Liang} and Jiang, {Ming Chung}",
year = "2008",
month = "11",
doi = "10.1080/15376510802428609",
language = "English",
volume = "18",
pages = "771--776",
journal = "Toxicology Mechanisms and Methods",
issn = "1537-6516",
publisher = "Informa Healthcare",
number = "9",

}

TY - JOUR

T1 - CAS enhances chemotherapeutic drug-induced p53 accumulation and apoptosis

T2 - Use of CAS for high-sensitivity anticancer drug screening

AU - Liao, Ching Fong

AU - Luo, Shue Fen

AU - Tsai, Chin Shaw Stella

AU - Tsao, Tang Yi

AU - Chen, Shun Liang

AU - Jiang, Ming Chung

PY - 2008/11

Y1 - 2008/11

N2 - Cells attacked by cytotoxic toxins may express apoptosis-related proteins such as p53 to kill themselves, so as not to affect surrounding healthy cells. These apoptosis-related proteins are also crucial for inducing apoptosis of tumor cells in cancer chemotherapy. CSE1L/CAS is a cellular apoptosis susceptibility protein that plays important roles in mediating cell apoptosis induced by various cytotoxic toxins and chemotherapeutic drugs. Our studies showed that CAS over-expression increased p53 accumulation and apoptosis induced by 5-fluorouracil, doxorubicin, cisplatin, and tamoxifen in HT-29 cancer cells. A method based on coexpression of CAS with green fluorescence protein (GFP) was developed for high-sensitivity anticancer drug screening. Cancer cells transfected with CAS- and GFP-expressing vectors or the control and GFP-expressing vectors were grown on 96-well microplates, treated with compounds to be screened, and detected with a microplate fluorescence reader. GFP fluorescence decreased following cancer cell death induced by the anticancer compounds. CAS transfection enhanced the cytotoxicities of anticancer compounds and therefore increased the decline in GFP fluorescence. Thus, anticancer compounds could be identified more sensitively. Our study indicates that CAS is an important p53 and apoptosis regulator and may be used for high-throughput anticancer drug screening as well as cytotoxic toxin assays.

AB - Cells attacked by cytotoxic toxins may express apoptosis-related proteins such as p53 to kill themselves, so as not to affect surrounding healthy cells. These apoptosis-related proteins are also crucial for inducing apoptosis of tumor cells in cancer chemotherapy. CSE1L/CAS is a cellular apoptosis susceptibility protein that plays important roles in mediating cell apoptosis induced by various cytotoxic toxins and chemotherapeutic drugs. Our studies showed that CAS over-expression increased p53 accumulation and apoptosis induced by 5-fluorouracil, doxorubicin, cisplatin, and tamoxifen in HT-29 cancer cells. A method based on coexpression of CAS with green fluorescence protein (GFP) was developed for high-sensitivity anticancer drug screening. Cancer cells transfected with CAS- and GFP-expressing vectors or the control and GFP-expressing vectors were grown on 96-well microplates, treated with compounds to be screened, and detected with a microplate fluorescence reader. GFP fluorescence decreased following cancer cell death induced by the anticancer compounds. CAS transfection enhanced the cytotoxicities of anticancer compounds and therefore increased the decline in GFP fluorescence. Thus, anticancer compounds could be identified more sensitively. Our study indicates that CAS is an important p53 and apoptosis regulator and may be used for high-throughput anticancer drug screening as well as cytotoxic toxin assays.

KW - Anticancer drugs

KW - Apoptosis

KW - CAS

KW - Green fluorescence protein

KW - High-throughput screening

KW - p53

UR - http://www.scopus.com/inward/record.url?scp=57349097228&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57349097228&partnerID=8YFLogxK

U2 - 10.1080/15376510802428609

DO - 10.1080/15376510802428609

M3 - Article

AN - SCOPUS:57349097228

VL - 18

SP - 771

EP - 776

JO - Toxicology Mechanisms and Methods

JF - Toxicology Mechanisms and Methods

SN - 1537-6516

IS - 9

ER -